Research output per year
Research output per year
Fingerprint
Dive into the research topics where Elena Di Gennaro is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Epigenetic Approaches to Overcome Fluoropyrimidines Resistance in Solid Tumors
Grumetti, L., Lombardi, R., Iannelli, F., Pucci, B., Avallone, A., Di Gennaro, E. & Budillon, A., Feb 1 2022, In: Cancers. 14, 3, 695.Research output: Contribution to journal › Review article › peer-review
Open Access -
HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation
Roca, M. S., Moccia, T., Iannelli, F., Testa, C., Vitagliano, C., Minopoli, M., Camerlingo, R., De Riso, G., De Cecio, R., Bruzzese, F., Conte, M., Altucci, L., Di Gennaro, E., Avallone, A., Leone, A. & Budillon, A., Dec 2022, In: Journal of Experimental and Clinical Cancer Research. 41, 1, 83.Research output: Contribution to journal › Article › peer-review
Open Access -
Effect of Bevacizumab in Combination with Standard Oxaliplatin-Based Regimens in Patients with Metastatic Colorectal Cancer: A Randomized Clinical Trial
Avallone, A., Piccirillo, M. C., Nasti, G., Rosati, G., Carlomagno, C., Di Gennaro, E., Romano, C., Tatangelo, F., Granata, V., Cassata, A., Silvestro, L., De Stefano, A., Aloj, L., Vicario, V., Nappi, A., Leone, A., Bilancia, D., Arenare, L., Petrillo, A., Lastoria, S., & 6 others, 2021, In: JAMA network open. e2118475.Research output: Contribution to journal › Article › peer-review
Open Access -
HSP90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancer
Lombardi, R., Sonego, M., Pucci, B., Addi, L., Iannelli, F., Capone, F., Alfano, L., Roca, M. S., Milone, M. R., Moccia, T., Costa, A., Di Gennaro, E., Bruzzese, F., Baldassarre, G. & Budillon, A., Apr 2021, In: Molecular Oncology. 15, 4, p. 1005-1023 19 p.Research output: Contribution to journal › Article › peer-review
Open Access -
HSP90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancer: Molecular Oncology
Lombardi, R., Sonego, M., Pucci, B., Addi, L., Iannelli, F., Capone, F., Alfano, L., Roca, M. S., Milone, M. R., Moccia, T., Costa, A., Di Gennaro, E., Bruzzese, F., Baldassarre, G. & Budillon, A., 2021, In: Mol. Oncol.. 15, 4, p. 1005-1023 19 p.Research output: Contribution to journal › Article › peer-review